default author photo

Joachim G. Aerts

Erasmus University Rotterdam (EUR) - Department of Pulmonary Diseases

Rotterdam

Netherlands

  • Erasmus University Rotterdam (EUR) - Department of Pulmonary Diseases

SCHOLARLY PAPERS

6

DOWNLOADS

184

TOTAL CITATIONS

0

Scholarly Papers (6)

Actions:
Email selected abstracts
1.

Lurbinectedin Shows Clinical Activity and Immune-Modulatory Functions in Patients with Pre-Treated Small Cell Lung Cancer and Malignant Pleural Mesothelioma

Number of pages: 41 Posted: 21 Apr 2022
Daphne W. Dumoulin, L. Cantini, R. Cornelissen, Madelief Vink, Larissa Klaase, N. Tebayna, Joanne M. Mankor, S.J. Baart, Rudi Hendriks, A-M.C. Dingemans, Marcella Willemsen and Joachim G. Aerts
Erasmus University Rotterdam (EUR) - Department of Pulmonary Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), University Medical Center Rotterdam - Department of Pulmonary Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), University Medical Center Rotterdam - Department of Pulmonary Medicine, Erasmus University Rotterdam, affiliation not provided to SSRN and Erasmus University Rotterdam (EUR) - Department of Pulmonary Diseases
Downloads 47 (1,097,529)

Abstract:

Loading...

lurbinectedin, small cell lung cancer/SCLC, malignant pleural mesothelioma/MPM, Immunotherapy, immune monitoring

2.

Key Insights from Cross-Continental Technology Transfer of ATMP Production: A Case Study Concerning AKT-DC

Number of pages: 4 Posted: 20 Jan 2026
Koen Bezemer, Rowan de Haan and Joachim G. Aerts
Erasmus MC, Erasmus University Rotterdam (EUR) - Department of Pulmonary Diseases and Erasmus University Rotterdam (EUR) - Department of Pulmonary Diseases
Downloads 36 (1,236,159)

Abstract:

Loading...

ATMP, Technology Transfer, AKT-DC

3.

Low-Dose JAK3-Inhibition Improves Anti-Tumor T-Cell Immunity and Immunotherapy Efficacy

Number of pages: 38 Posted: 04 May 2021
Floris Dammeijer, Mandy van Gulijk, Larissa Klaase, Menno van Nimwegen, Rachid Bouzid, Robin Hoogenboom, Linda Joosse, Rudi Hendriks, Thorbald van Hall and Joachim G. Aerts
University Medical Center Rotterdam - Erasmus MC Cancer Institute, University Medical Center Rotterdam - Department of Pulmonary Medicine, University Medical Center Rotterdam - Department of Pulmonary Medicine, University Medical Center Rotterdam - Department of Pulmonary Medicine, University Medical Center Rotterdam - Department of Pulmonary Medicine, University Medical Center Rotterdam - Department of Pulmonary Medicine, University Medical Center Rotterdam - Erasmus MC Cancer Institute, University Medical Center Rotterdam - Department of Pulmonary Medicine, Leiden University Medical Center - Department of Medical Oncology and Erasmus University Rotterdam (EUR) - Department of Pulmonary Diseases
Downloads 33 (1,277,121)

Abstract:

Loading...

4.

Outcome and Safety of Lurbinectedin as Compassionate Use in Extensive Stage Small Cell Lung Cancer: A Multicentric International Cohort

Number of pages: 22 Posted: 02 Jun 2025
Daniela Scattolin, A-M.C. Dingemans, Alessandro Dal Maso, Valentina Guarneri, Joachim G. Aerts, Giulia Pasello and Daphne W. Dumoulin
affiliation not provided to SSRN, Erasmus University Rotterdam, Istituto Oncologico Veneto – IRCCS, affiliation not provided to SSRN, Erasmus University Rotterdam (EUR) - Department of Pulmonary Diseases, affiliation not provided to SSRN and Erasmus University Rotterdam (EUR) - Department of Pulmonary Medicine
Downloads 31 (1,304,549)

Abstract:

Loading...

small cell lung cancer, lurbinectedin, real-world, effectiveness

5.

OX40 Agonism Enhances Efficacy of PD-L1 Checkpoint Blockade by Shifting the Cytotoxic T Cell Differentiation Spectrum

Number of pages: 47 Posted: 15 Feb 2022
Guillaume Beyrend, Tetje van der Sluis, Esmé van der Gracht, Tamim Abdelaal, Simon Jochems, Robert Belderbos, Thomas Wesselink, Suzanne van Duikeren, Floortje van Haften, Anke Redeker, Elham Beyranvand Nejad, Marcel G.M. Camps, Kees Franken, Margot Linssen, Peter Hohenstein, Noel F. C. C. de Miranda, Hailiang Mei, Adriaan Bins, John Haanen, Joachim G. Aerts, Ferry A. Ossendorp and Ramon Arens
Leiden University - Department of Immunology, Leiden University - Department of Immunology, Leiden University - Department of Immunology, Delft University of Technology - Pattern Recognition and Bioinformatics, Leiden University - Department of Parasitology, Erasmus University Rotterdam (EUR) - Department of Pulmonary Diseases, Leiden University - Department of Immunology, Leiden University - Department of Immunology, Leiden University - Department of Immunology, Leiden University - Department of Immunology, Leiden University - Department of Immunology, Leiden University - Department of Immunology, Leiden University - Department of Infectious Diseases, Leiden University - Central Animal and Transgenic Facility, Leiden University - Department of Human Genetics, Leiden University, Medical Center (LUMC), Department of Pathology, Leiden University - Sequencing Analysis Support Core, University of Amsterdam - Department of Internal Medicine, Netherlands Cancer Institute - Division of Molecular Oncology and Immunology, Erasmus University Rotterdam (EUR) - Department of Pulmonary Diseases, Leiden University - Department of Immunology and Leiden University - Department of Parasitology
Downloads 25 (1,385,945)

Abstract:

Loading...

6.

Regional variations in molecular testing and treatment of patients with metastatic NSCLC in the Netherlands

Number of pages: 19 Posted: 18 Feb 2026
Jente M. Klok, Z.L.R. Kaplan, Marthe S. Paats, A.H. Eijkelboom, Jan von der Thüsen, Hester F. Lingsma, Joachim G. Aerts and David van Klaveren
Erasmus University Rotterdam (EUR) - Department of Pulmonary Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), Erasmus University Rotterdam (EUR) - Department of Public Health, Erasmus University Rotterdam (EUR) - Department of Pulmonary Diseases and affiliation not provided to SSRN
Downloads 12 (1,526,714)

Abstract:

Loading...

NSCLC, molecular testing, targeted therapy, regional variations